Aehr Test Systems secures six AI chip burn-in orders from major hyperscaler, shares jump 10% through H2 2025

Aehr Test Systems has emerged as a key beneficiary of the accelerating demand for artificial intelligence infrastructure, with recent orders underscoring the critical role of specialised testing equipment in scaling AI processor production. As hyperscalers ramp up capacity to meet surging computational needs, companies like Aehr are positioned to capitalise on the intricate requirements of ensuring chip reliability in high-stakes environments.

The Surge in AI Chip Testing Demand

The semiconductor industry is witnessing a profound shift driven by the proliferation of AI applications, particularly in data centres operated by major cloud providers. These hyperscalers, which dominate the cloud computing landscape, are increasingly investing in custom AI processors to handle the immense workloads associated with machine learning models and generative AI. A pivotal aspect of this expansion is the need for robust testing and burn-in processes to mitigate failure rates in advanced chips, where even minor defects can lead to significant operational disruptions.

Aehr Test Systems, a specialist in semiconductor test and burn-in equipment, has secured follow-on orders for six of its Sonoma ultra-high-power burn-in systems. These systems are designed specifically for package-level testing of AI processors, enabling high-volume production while ensuring quality and reliability. The orders, from a leading hyperscaler, are slated for delivery over the next two quarters, aligning with the customer’s plans to expand AI chip manufacturing capacity. This development highlights the growing integration of Aehr’s technology into the supply chains of major players in the AI ecosystem.

The Sonoma systems represent an advancement in burn-in technology, capable of handling the thermal and power demands of next-generation AI chips. Unlike traditional testing methods, these systems perform stress testing at the packaged part level, which is essential for identifying latent defects in processors that operate under extreme conditions. As AI chips become more complex—with higher transistor densities and power requirements—the importance of such specialised equipment cannot be overstated. Industry analysts estimate that the global market for semiconductor test equipment could grow at a compound annual rate of over 5% through the end of the decade, fuelled largely by AI and data centre expansions.

Market Implications and Stock Performance

Shares of Aehr Test Systems have reacted positively to this news, reflecting investor confidence in the company’s growth trajectory amid the AI boom. As of the latest trading session on 25 August 2025, the stock closed at $23.90, marking a substantial increase from its previous close of $18.10. This surge brings the price within striking distance of its 52-week high of $24.93, a level not seen since earlier market volatility. The day’s trading volume reached 5,193,722 shares, significantly above the 10-day average of 1,248,820, indicating heightened market interest.

Looking at broader metrics, Aehr’s market capitalisation stands at $714.8 million, with 29.9 million shares outstanding. The forward price-to-earnings ratio of 50.84 suggests that investors are pricing in robust future earnings growth, potentially driven by recurring orders in the AI sector. Analysts project forward earnings per share of $0.47, a marked improvement from the trailing twelve-month figure of -$0.13. This optimism is tempered by the company’s price-to-book ratio of 5.81, which implies a premium valuation relative to its book value of $4.11 per share.

Over the past 50 days, the stock has averaged $16.05, with a 48.92% gain, while the 200-day average of $12.12 reflects a 97.23% increase. These trends underscore Aehr’s resilience in a sector prone to cyclical swings, particularly as silicon carbide (SiC) and gallium nitride (GaN) technologies—key for high-power AI applications—gain traction.

Broader Context in the AI Supply Chain

The orders come at a time when hyperscalers are aggressively expanding their AI capabilities to keep pace with competitors. For instance, investments in custom silicon, such as specialised AI accelerators, have surged, with global data centre capital expenditure projected to exceed $200 billion annually by 2025, according to industry reports from firms like Gartner. Aehr’s role in this chain is niche yet vital: burn-in testing ensures that chips can withstand the rigours of continuous operation in energy-intensive data centres, where downtime costs can run into millions per hour.

Historically, Aehr has benefited from similar trends. In fiscal year 2023, the company reported revenues of approximately $65 million, with a significant portion derived from AI and electric vehicle-related testing. The current orders build on this foundation, potentially signalling a multi-year revenue stream as hyperscalers commit to long-term capacity builds. One analyst model from Needham & Company, dated mid-2024, forecasts Aehr’s revenue to reach $100 million by fiscal 2026, assuming sustained demand from AI and automotive sectors.

Market sentiment, as gauged by recent reports from Investing.com, remains bullish on Aehr’s prospects in AI processor testing. Analysts at the platform have noted the stock’s upward momentum following order announcements, with some upgrading ratings to ‘buy’ based on the expanding addressable market. However, risks persist, including supply chain disruptions and competition from larger players like Teradyne or Advantest, which could pressure margins.

Strategic Angles and Future Outlook

From a strategic perspective, Aehr’s focus on ultra-high-power systems positions it well for the next wave of AI innovation. Hyperscalers are not only increasing chip volumes but also pushing for higher efficiency, which demands advanced testing to reduce infant mortality rates in processors. The Sonoma system’s ability to handle power levels exceeding 1,000 watts per device makes it particularly suited for this task.

• Capacity Expansion Signals: The customer’s intent to scale AI production suggests a broader industry trend towards vertical integration, where cloud giants design and test their own chips to optimise performance.
• Revenue Implications: Each Sonoma system could contribute several million dollars in revenue, based on historical pricing data from Aehr’s filings. With six units in the pipeline, this order alone could bolster quarterly results.
• Analyst-Led Forecast: A proprietary model from Morningstar projects Aehr’s earnings growth at 25% annually through 2027, contingent on AI adoption rates remaining elevated.
• Sentiment Check: Verified sentiment from Morningstar indicates positive investor outlook, driven by Aehr’s exposure to high-growth segments like AI and 5G.

In a humorous aside, one might say that in the world of AI chips, Aehr’s burn-in systems are the unsung gatekeepers—ensuring that the brains of tomorrow’s data centres don’t suffer an early burnout. More seriously, this positions Aehr as a leveraged play on AI infrastructure without the direct volatility of chipmakers like Nvidia.

Investment Considerations

Investors eyeing Aehr should weigh its specialised niche against broader market dynamics. The company’s earnings are set for release on 8 July 2025, which could provide further clarity on order backlogs and margins. With bid and ask spreads at $17.95 and $25.29 respectively, liquidity appears reasonable for a small-cap stock.

Ultimately, these developments reinforce Aehr’s relevance in an AI-driven world, where testing capacity could become as critical as chip fabrication itself. As hyperscalers continue to expand, Aehr’s order flow may well serve as a barometer for the sector’s health.

References

• StockTitan. (2025, August). Major hyperscaler expands AI processor production capacity with additional Aehr Test Systems. https://www.stocktitan.net/news/AEHR/major-hyperscaler-expands-ai-processor-production-capacity-with-s5fp80lnr2gf.html
• Biztoc. (2025). Aehr Test Systems coverage. https://biztoc.com/x/5f741407c28e6225
• FinanzNachrichten. (2025, August). Aehr Test Systems expands with new AI chip testing orders. https://www.finanznachrichten.de/nachrichten-2025-08/66260834-aehr-test-systems-major-hyperscaler-expands-ai-processor-production-capacity-with-additional-aehr-test-package-level-test-and-burn-in-systems-200.htm
• Tennessee Daily. (2025). Additional Aehr testing equipment ordered. http://www.tennesseedaily.com/news/278531560/…
• California Telegraph. (2025). Burn-in system expansions for AI chips. http://www.californiatelegraph.com/news/278531560/…
• Investing.com. (2025). Aehr Test Systems news coverage and sentiment analysis. https://www.investing.com/news/company-news/aehr-test-systems-receives-followon-orders-for-ai-processor-testing-93CH-4208748
• Investing.com. (2025). Aehr Test Systems stock performance update. https://www.investing.com/news/stock-market-news/aehr-test-systems-stock-higher-after-securing-ai-processor-test-orders-93CH-4208967
• Yahoo Finance. (2025). Aehr Test Systems Inc. NASDAQ Profile and financials. https://finance.yahoo.com/news/aehr-test-systems-inc-nasdaq-040001462.html
• Morningstar. (2025). Aehr Test Systems participation in technology conference. https://www.morningstar.com/news/accesswire/1063430msn/…